IRE1 RNase controls CD95-mediated cell death.

CD95 Cell Death ER Stress IRE1 Unfolded Protein Response

Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
21 Feb 2024
Historique:
received: 31 03 2023
accepted: 03 02 2024
revised: 18 01 2024
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

Signalling by the Unfolded Protein Response (UPR) or by the Death Receptors (DR) are frequently activated towards pro-tumoral outputs in cancer. Herein, we demonstrate that the UPR sensor IRE1 controls the expression of the DR CD95/Fas, and its cell death-inducing ability. Both genetic and pharmacologic blunting of IRE1 activity increased CD95 expression and exacerbated CD95L-induced cell death in glioblastoma (GB) and Triple-Negative Breast Cancer (TNBC) cell lines. In accordance, CD95 mRNA was identified as a target of Regulated IRE1-Dependent Decay of RNA (RIDD). Whilst CD95 expression is elevated in TNBC and GB human tumours exhibiting low RIDD activity, it is surprisingly lower in XBP1s-low human tumour samples. We show that IRE1 RNase inhibition limited CD95 expression and reduced CD95-mediated hepatic toxicity in mice. In addition, overexpression of XBP1s increased CD95 expression and sensitized GB and TNBC cells to CD95L-induced cell death. Overall, these results demonstrate the tight IRE1-mediated control of CD95-dependent cell death in a dual manner through both RIDD and XBP1s, and they identify a novel link between IRE1 and CD95 signalling.

Identifiants

pubmed: 38383861
doi: 10.1038/s44319-024-00095-9
pii: 10.1038/s44319-024-00095-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondation ARC pour la Recherche sur le Cancer (ARC)
ID : PDF20171206671
Organisme : Fondation ARC pour la Recherche sur le Cancer (ARC)
ID : PJA20181207700
Organisme : Fondation de France (Foundation of France)
ID : N/A
Organisme : EC | H2020 | PRIORITY 'Excellent science' | H2020 Marie Skłodowska-Curie Actions (MSCA)
ID : ITN-675448
Organisme : Institut National Du Cancer (INCa)
ID : PLBIO 2018,2019
Organisme : Ligue Contre le Cancer (French League Against Cancer)
ID : N/A
Organisme : Association La Vannetaise
ID : N/A
Organisme : Association La Josselinaise des femmes
ID : N/A
Organisme : Centre Eugène Marquis
ID : N/A
Organisme : Université de Rennes 1 (University of Rennes 1)
ID : Défis Scientifiques

Informations de copyright

© 2024. The Author(s).

Références

Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luis A, McCarthy N, Montibeller L, More S et al (2019) Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications. FEBS J 286:241–278
pubmed: 30027602 doi: 10.1111/febs.14608
Anderson DJ, Le Moigne R, Djakovic S, Kumar B, Rice J, Wong S, Wang J, Yao B, Valle E, Kiss von Soly S et al (2015) Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell 28:653–665
pubmed: 26555175 pmcid: 4941640 doi: 10.1016/j.ccell.2015.10.002
Annibaldi A, Walczak H (2020) Death receptors and their ligands in inflammatory disease and cancer. Cold Spring Harb Perspect Biol 12:a036384
pubmed: 31988141 pmcid: 7461759 doi: 10.1101/cshperspect.a036384
Auyeung VC, Downey MS, Thamsen M, Wenger TA, Backes BJ, Sheppard D, Papa FR (2022) IRE1α drives lung epithelial progenitor dysfunction to establish a niche for pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 322(4):L564–L580
pubmed: 35170357 pmcid: 8957349 doi: 10.1152/ajplung.00408.2021
Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V (2012) Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells. Brain Pathol 22:159–174
pubmed: 21790828 doi: 10.1111/j.1750-3639.2011.00515.x
Benetatos CA, Mitsuuchi Y, Burns JM, Neiman EM, Condon SM, Yu G, Seipel ME, Kapoor GS, Laporte MG, Rippin SR et al (2014) Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models. Mol Cancer Ther 13:867–879
pubmed: 24563541 doi: 10.1158/1535-7163.MCT-13-0798
Cazanave SC, Mott JL, Bronk SF, Werneburg NW, Fingas CD, Meng XW, Finnberg N, El-Deiry WS, Kaufmann SH, Gores GJ (2011) Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem 286:39336–39348
pubmed: 21941003 pmcid: 3234758 doi: 10.1074/jbc.M111.280420
Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y et al (2014) XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 508:103–107
pubmed: 24670641 pmcid: 4105133 doi: 10.1038/nature13119
Condon SM, Mitsuuchi Y, Deng Y, LaPorte MG, Rippin SR, Haimowitz T, Alexander MD, Kumar PT, Hendi MS, Lee YH et al (2014) Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies. J Med Chem 57:3666–3677
pubmed: 24684347 doi: 10.1021/jm500176w
Doultsinos D, McMahon M, Voutetakis K, Obacz J, Pineau R, Jouan F, Le Reste P-J, Obiedat A, Samal J, Patterson JB et al (2019) Control of glioblastoma differentiated-to-stem cell reprogramming by IRElα/XBPls signaling. Preprint at Biorxiv https://doi.org/10.1101/594630
Drachsler M, Kleber S, Mateos A, Volk K, Mohr N, Chen S, Cirovic B, Tüttenberg J, Gieffers C, Sykora J et al (2016) CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells. Cell Death Dis 7:e2209
pubmed: 27124583 pmcid: 4855647 doi: 10.1038/cddis.2016.102
Favaro F, Both D, Derks IAM, Spaargaren M, Muñoz-Pinedo C, Eldering E (2023) Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies. Oncogenesis 12:6
pubmed: 36755015 pmcid: 9908905 doi: 10.1038/s41389-023-00450-w
Filliol A, Farooq M, Piquet-Pellorce C, Genet V, Dimanche-Boitrel MT, Vandenabeele P, Bertrand MJM, Samson M, Le Seyec J (2017) RIPK1 protects hepatocytes from death in Fas-induced hepatitis. Sci Rep 7:9205
pubmed: 28835677 pmcid: 5569041 doi: 10.1038/s41598-017-09789-8
Fritsche H, Heilmann T, Tower RJ, Hauser C, von Au A, El-Sheikh D, Campbell GM, Alp G, Schewe D, Hubner S et al (2015) TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model. Oncotarget 6:9502–9516
pubmed: 25909161 pmcid: 4496234 doi: 10.18632/oncotarget.3321
Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, Kellert B, Gollnick H, Silke J, Leverkus M (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187:1037–1054
pubmed: 20038679 pmcid: 2806279 doi: 10.1083/jcb.200904158
Glab JA, Doerflinger M, Nedeva C, Jose I, Mbogo GW, Paton JC, Paton AW, Kueh AJ, Herold MJ, Huang DC et al (2017) DR5 and caspase-8 are dispensable in ER stress-induced apoptosis. Cell Death Differ 24:944–950
pubmed: 28409774 pmcid: 5423120 doi: 10.1038/cdd.2017.53
Guégan JP, Pollet J, Ginestier C, Charafe-Jauffret E, Peter ME, Legembre P (2021) CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism. iScience 24:103538
pubmed: 34917906 pmcid: 8666665 doi: 10.1016/j.isci.2021.103538
Hagenlocher C, Siebert R, Taschke B, Wieske S, Hausser A, Rehm M (2022) ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic β cells. Cell Death Discov 8:34
pubmed: 35075141 pmcid: 8786928 doi: 10.1038/s41420-022-00830-y
Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, Hagen A, Backes BJ, Oakes SA, Papa FR (2009) IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 138:562–575
pubmed: 19665977 pmcid: 2762408 doi: 10.1016/j.cell.2009.07.017
Harnoss JM, Le Thomas A, Reichelt M, Guttman O, Wu TD, Marsters SA, Shemorry A, Lawrence DA, Kan D, Segal E et al (2020) IRE1α disruption in triple-negative breast cancer cooperates with antiangiogenic therapy by reversing ER stress adaptation and remodeling the tumor microenvironment. Cancer Res 80:2368–2379
pubmed: 32265225 pmcid: 7272310 doi: 10.1158/0008-5472.CAN-19-3108
Hassler JR, Scheuner DL, Wang S, Han J, Kodali VK, Li P, Nguyen J, George JS, Davis C, Wu SP et al (2015) The IRE1α/XBP1s pathway is essential for the glucose response and protection of β cells. PLoS Biol 13:e1002277
pubmed: 26469762 pmcid: 4607427 doi: 10.1371/journal.pbio.1002277
He Q, Lee DI, Rong R, Yu M, Luo X, Klein M, El-Deiry WS, Huang Y, Hussain A, Sheikh MS (2002) Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene 21:2623–2633
pubmed: 11965535 doi: 10.1038/sj.onc.1205345
Hellwig CT, Delgado ME, Skoko J, Dyck L, Hanna C, Wentges A, Langlais C, Hagenlocher C, Mack A, Dinsdale D et al (2022) Proteasome inhibition triggers the formation of TRAIL receptor 2 platforms for caspase-8 activation that accumulate in the cytosol. Cell Death Differ 29:147–155
pubmed: 34354257 doi: 10.1038/s41418-021-00843-7
Hillert-Richter LK, Lavrik IN (2021) Measuring composition of CD95 death-inducing signaling complex and processing of procaspase-8 in this complex. J Vis Exp (174):e62842. https://doi.org/10.3791/62842
Iurlaro R, Munoz-Pinedo C (2016) Cell death induced by endoplasmic reticulum stress. FEBS J 283:2640–2652
pubmed: 26587781 doi: 10.1111/febs.13598
Iurlaro R, Puschel F, Leon-Annicchiarico CL, O’Connor H, Martin SJ, Palou-Gramon D, Lucendo E, Munoz-Pinedo C (2017) Glucose deprivation induces ATF4-mediated apoptosis through TRAIL death receptors. Mol Cell Biol 37:e00479–16
pubmed: 28242652 pmcid: 5477549 doi: 10.1128/MCB.00479-16
Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, Thorne R, Zhang XD, Hersey P (2007) Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Cancer Res 67:5880–5888
pubmed: 17575157 doi: 10.1158/0008-5472.CAN-07-0213
Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC, Bouillet P, Thomas HE, Borner C, Silke J et al (2009) XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460:1035–1039
pubmed: 19626005 pmcid: 2956120 doi: 10.1038/nature08229
Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–5588
pubmed: 8521815 pmcid: 394672 doi: 10.1002/j.1460-2075.1995.tb00245.x
Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W, Sykora J, Kuhn A et al (2008) Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13:235–248
pubmed: 18328427 doi: 10.1016/j.ccr.2008.02.003
Lafont E (2020) Stress management: death receptor signalling and cross-talks with the unfolded protein response in cancer. Cancers 12:1113
pubmed: 32365592 pmcid: 7281445 doi: 10.3390/cancers12051113
Lam M, Lawrence DA, Ashkenazi A, Walter P (2018) Confirming a critical role for death receptor 5 and caspase-8 in apoptosis induction by endoplasmic reticulum stress. Cell Death Differ 25:1530–1531
pubmed: 29991746 pmcid: 6113221 doi: 10.1038/s41418-018-0155-y
Lam M, Marsters SA, Ashkenazi A, Walter P (2020) Misfolded proteins bind and activate death receptor 5 to induce apoptosis during unresolved endoplasmic reticulum stress. Elife 9:e52291
pubmed: 31904339 pmcid: 7041945 doi: 10.7554/eLife.52291
Le Reste PJ, Pineau R, Voutetakis K, Samal J, Jégou G, Lhomond S, Gorman AM, Samali A, Patterson JB, Zeng Q et al (2020) Local intracerebral Inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo. Cancer Lett 494:73–83
pubmed: 32882336 doi: 10.1016/j.canlet.2020.08.028
Lee A-H, Heidtman K, Hotamisligil GS, Glimcher LH (2011) Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion. Proc Natl Acad Sci USA 108:8885–8890
pubmed: 21555585 pmcid: 3102350 doi: 10.1073/pnas.1105564108
Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F et al (2018) Dual IRE1 RNase functions dictate glioblastoma development. EMBO Mol Med 10:e7929
pubmed: 29311133 pmcid: 5840541 doi: 10.15252/emmm.201707929
Li T, Su L, Lei Y, Liu X, Zhang Y, Liu X (2015) DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. J Biol Chem 290:11108–11118
pubmed: 25770212 pmcid: 4409269 doi: 10.1074/jbc.M115.645333
Lindner P, Christensen SB, Nissen P, Møller JV, Engedal N (2020) Cell death induced by the ER stressor thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response components. Cell Commun Signal 18:12
pubmed: 31987044 pmcid: 6986015 doi: 10.1186/s12964-019-0499-z
Lipson KL, Ghosh R, Urano F (2008) The role of IRE1alpha in the degradation of insulin mRNA in pancreatic beta-cells. PLoS ONE 3:e1648
pubmed: 18286202 pmcid: 2241665 doi: 10.1371/journal.pone.0001648
Logue SE, McGrath EP, Cleary P, Greene S, Mnich K, Almanza A, Chevet E, Dwyer RM, Oommen A, Legembre P et al (2018) Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 9:3267
pubmed: 30111846 pmcid: 6093931 doi: 10.1038/s41467-018-05763-8
Lorenz R, Bernhart SH, Höner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6:26
pubmed: 22115189 pmcid: 3319429 doi: 10.1186/1748-7188-6-26
Lu M, Lawrence DA, Marsters S, Acosta-Alvear D, Kimmig P, Mendez AS, Paton AW, Paton JC, Walter P, Ashkenazi A (2014) Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science 345:98–101
pubmed: 24994655 pmcid: 4284148 doi: 10.1126/science.1254312
Madeira F, Pearce M, Tivey ARN, Basutkar P, Lee J, Edbali O, Madhusoodanan N, Kolesnikov A, Lopez R (2022) Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res 50:W276–W279
pubmed: 35412617 pmcid: 9252731 doi: 10.1093/nar/gkac240
Martinez-Turtos A, Paul R, Grima-Reyes M, Issaoui H, Krug A, Mhaidly R, Bossowski JP, Chiche J, Marchetti S, Verhoeyen E et al (2022) IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response. Oncoimmunology 11:2116844
pubmed: 36046811 pmcid: 9423862 doi: 10.1080/2162402X.2022.2116844
Martin-Perez R, Niwa M, Lopez-Rivas A (2012) ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2. Apoptosis 17:349–363
pubmed: 22072062 pmcid: 4096301 doi: 10.1007/s10495-011-0673-2
Martín-Pérez R, Palacios C, Yerbes R, Cano-González A, Iglesias-Serret D, Gil J, Reginato MJ, López-Rivas A (2014) Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway. Cancer Res 74:1766–1777
pubmed: 24453000 pmcid: 4053205 doi: 10.1158/0008-5472.CAN-13-1747
Maurel M, Chevet E, Tavernier J, Gerlo S (2014) Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci 39:245–254
pubmed: 24657016 doi: 10.1016/j.tibs.2014.02.008
McGrath EP, Centonze FG, Chevet E, Avril T, Lafont E (2021) Death sentence: the tale of a fallen endoplasmic reticulum. Biochim Biophys Acta Mol Cell Res 1868:119001
pubmed: 33705817 doi: 10.1016/j.bbamcr.2021.119001
Miani M, Colli ML, Ladrière L, Cnop M, Eizirik DL (2012) Mild endoplasmic reticulum stress augments the proinflammatory effect of IL-1β in pancreatic rat β-cells via the IRE1α/XBP1s pathway. Endocrinology 153:3017–3028
pubmed: 22529213 doi: 10.1210/en.2011-2090
Moore K, Hollien J (2015) Ire1-mediated decay in mammalian cells relies on mRNA sequence, structure, and translational status. Mol Biol Cell 26:2873–2884
pubmed: 26108623 pmcid: 4571326 doi: 10.1091/mbc.E15-02-0074
Munoz-Pinedo C, Lopez-Rivas A (2018) A role for caspase-8 and TRAIL-R2/DR5 in ER-stress-induced apoptosis. Cell Death Differ 25:226
pubmed: 28984868 doi: 10.1038/cdd.2017.155
Nguyên DT, Kebache S, Fazel A, Wong HN, Jenna S, Emadali A, Lee E, Bergeron JJM, Kaufman RJ, Larose L et al (2004) Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress. Mol Biol Cell 15:4248–4260
pubmed: 15201339 pmcid: 515356 doi: 10.1091/mbc.e03-11-0851
Obacz J, Archambeau J, Lafont E, Nivet M, Martin S, Aubry M, Voutetakis K, Pineau R, Boniface R, Sicari D et al (2023) IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma. Neuro Oncol noad256. https://doi.org/10.1093/neuonc/noad256
Oikawa D, Tokuda M, Hosoda A, Iwawaki T (2010) Identification of a consensus element recognized and cleaved by IRE1 alpha. Nucleic Acids Res 38:6265–6273
pubmed: 20507909 pmcid: 2952871 doi: 10.1093/nar/gkq452
Pelizzari-Raymundo D, Doultsinos D, Pineau R, Sauzay C, Koutsandreas T, Langlais T, Carlesso A, Gkotsi E, Negroni L, Avril T et al (2023) A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment. iScience 26:106687
pubmed: 37216120 pmcid: 10192531 doi: 10.1016/j.isci.2023.106687
Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa A, Delugin M, Combe C, Loriot S, Cubel G et al (2013) Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα. Cancer Res 73:4732–4743
pubmed: 23752693 pmcid: 3915716 doi: 10.1158/0008-5472.CAN-12-3989
Quijano-Rubio C, Silginer M, Weller M (2022) CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner. Cell Death Discov 8:341
pubmed: 35906203 pmcid: 9338300 doi: 10.1038/s41420-022-01133-y
Redente EF, Chakraborty S, Sajuthi S, Black BP, Edelman BL, Seibold MA, Riches DW (2020) Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis. JCI Insight 6:e141618
pubmed: 33290280 pmcid: 7821600 doi: 10.1172/jci.insight.141618
Risso V, Lafont E, Le Gallo M (2022) Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. Cell Death Dis 13:248
pubmed: 35301281 pmcid: 8931059 doi: 10.1038/s41419-022-04688-x
Risso V, Thomas M, Guével B, Lavigne R, Com E, Martin S, Nivet M, Pineau C, Negroni L, Lafont É et al (2023) Metalloprotease-mediated cleavage of CD95 ligand. FEBS J 290(12):3145–3164
pubmed: 36694998 doi: 10.1111/febs.16737
Rossin A, Miloro G, Hueber AO (2019) TRAIL and FasL functions in cancer and autoimmune diseases: towards an increasing complexity. Cancers 11:639
pubmed: 31072029 pmcid: 6563024 doi: 10.3390/cancers11050639
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675
pubmed: 22930834 pmcid: 5554542 doi: 10.1038/nmeth.2089
Shatnyeva OM, Kubarenko AV, Weber CEM, Pappa A, Schwartz-Albiez R, Weber ANR, Krammer PH, Lavrik IN (2011) Modulation of the CD95-induced apoptosis: the role of CD95 N-glycosylation. PLoS ONE 6:e19927
pubmed: 21625644 pmcid: 3097226 doi: 10.1371/journal.pone.0019927
Singh N, Lee YG, Shestova O, Ravikumar P, Hayer KE, Hong SJ, Lu XM, Pajarillo R, Agarwal S, Kuramitsu S et al (2020) Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction. Cancer Discov 10:552–567
pubmed: 32001516 pmcid: 7416790 doi: 10.1158/2159-8290.CD-19-0813
Stöhr D, Jeltsch A, Rehm M (2020a) TRAIL receptor signaling: From the basics of canonical signal transduction toward its entanglement with ER stress and the unfolded protein response. Int Rev Cell Mol Biol 351:57–99
pubmed: 32247582 doi: 10.1016/bs.ircmb.2020.02.002
Stöhr D, Schmid JO, Beigl TB, Mack A, Maichl DS, Cao K, Budai B, Fullstone G, Kontermann RE, Mürdter TE et al (2020b) Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids. Cell Death Differ 27:3037–3052
pubmed: 32433558 pmcid: 7560834 doi: 10.1038/s41418-020-0559-3
Sullivan GP, O’Connor H, Henry CM, Davidovich P, Clancy DM, Albert ML, Cullen SP, Martin SJ (2020) TRAIL receptors serve as stress-associated molecular patterns to promote ER-stress-induced inflammation. Dev Cell 52:714–730.e5
pubmed: 32109381 doi: 10.1016/j.devcel.2020.01.031
Thamsen M, Ghosh R, Auyeung VC, Brumwell A, Chapman HA, Backes BJ, Perara G, Maly DJ, Sheppard D, Papa FR (2019) Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung. PLoS ONE 14:e0209824
pubmed: 30625178 pmcid: 6326459 doi: 10.1371/journal.pone.0209824
Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME et al (2009) Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 119:2925–2941
pubmed: 19741297 pmcid: 2752072 doi: 10.1172/JCI38857
Tsuchiya Y, Saito M, Kadokura H, Miyazaki J-I, Tashiro F, Imagawa Y, Iwawaki T, Kohno K (2018) IRE1-XBP1 pathway regulates oxidative proinsulin folding in pancreatic β cells. J Cell Biol 217:1287–1301
pubmed: 29507125 pmcid: 5881499 doi: 10.1083/jcb.201707143
Tsunoda T, Takagi T (1999) Estimating transcription factor bindability on DNA. Bioinformatics 15:622–630
pubmed: 10487870 doi: 10.1093/bioinformatics/15.7.622
Upadhyay R, Boiarsky JA, Pantsulaia G, Svensson-Arvelund J, Lin MJ, Wroblewska A, Bhalla S, Scholler N, Bot A, Rossi JM et al (2021) A critical role for fas-mediated off-target tumor killing in T-cell immunotherapy. Cancer discovery 11:599–613
pubmed: 33334730 doi: 10.1158/2159-8290.CD-20-0756
Volkmann K, Lucas JL, Vuga D, Wang X, Brumm D, Stiles C, Kriebel D, Der-Sarkissian A, Krishnan K, Schweitzer C et al (2011) Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease. J Biol Chem 286:12743–12755
pubmed: 21303903 pmcid: 3069474 doi: 10.1074/jbc.M110.199737
Von Karstedt S, Montinaro A, Walczak H (2017) Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nat Rev Cancer 17(6):352–366
doi: 10.1038/nrc.2017.28
Voutetakis KD (In preparation) RNA sequence motif and structure in IRE1-mediated cleavage.
Yamaguchi H, Wang HG (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem 279:45495–45502
pubmed: 15322075 doi: 10.1074/jbc.M406933200
Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881–891
pubmed: 11779464 doi: 10.1016/S0092-8674(01)00611-0

Auteurs

Diana Pelizzari-Raymundo (D)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Victoria Maltret (V)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Manon Nivet (M)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Raphael Pineau (R)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Alexandra Papaioannou (A)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Xingchen Zhou (X)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Flavie Caradec (F)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Sophie Martin (S)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Matthieu Le Gallo (M)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Tony Avril (T)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Eric Chevet (E)

Inserm U1242, University of Rennes, Rennes, France.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.

Elodie Lafont (E)

Inserm U1242, University of Rennes, Rennes, France. elodie.lafont@inserm.fr.
Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. elodie.lafont@inserm.fr.

Classifications MeSH